#9;[(4-[(S)-2-TERT.-BUTOXYCARBONYLAMINO-2-[(S)-1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-PHENYL)-(DIETHOXYPHOSPHORYL)-METHYL]-PHOSPHONIC
Compound with spectra: 1 NMR
![#9;[(4-[(S)-2-TERT.-BUTOXYCARBONYLAMINO-2-[(S)-1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-PHENYL)-(DIETHOXYPHOSPHORYL)-METHYL]-PHOSPHONIC](/api/compound/4NGXrbb1k7J.png?ph=true&h=300&w=458 "#9;[(4-[(S)-2-TERT.-BUTOXYCARBONYLAMINO-2-[(S)-1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-PHENYL)-(DIETHOXYPHOSPHORYL)-METHYL]-PHOSPHONIC")
| SpectraBase Compound ID | 4NGXrbb1k7J |
|---|---|
| InChI | InChI=1S/C39H61N3O11P2/c1-9-49-54(46,50-10-2)37(55(47,51-11-3)52-12-4)30-20-18-28(19-21-30)24-33(42-38(45)53-39(6,7)8)36(44)41-27(5)31-22-23-34(32(25-31)35(40)43)48-26-29-16-14-13-15-17-29/h18-23,25,27,29,33,37H,9-17,24,26H2,1-8H3,(H2,40,43)(H,41,44)(H,42,45)/t27-,33-/m0/s1 |
| InChIKey | VCPJKIYYQVOVAM-CMVGPNDKSA-N |
| Mol Weight | 809.9 g/mol |
| Molecular Formula | C39H61N3O11P2 |
| Exact Mass | 809.378134 g/mol |
| Enantiomer InChIKey | VCPJKIYYQVOVAM-ZORMNXRFSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenyl-N-[1-(5,6,7,8-tetrahydro-2-naphthalenyl)ethyl]propanamide
DIASTEREOMER-13A
BOC-GLU-(O-TERT.-BUTYL)-TYR-[SO2C6H3(3-OH)(4-COOH)]-LEU-OBZL
BENZYLOXYCARBONYL-VALINE-(TERT-BUTYLOXYCARBONYL)LYSINE-VALINE-TYROSINE-PROLINE-O-TERT-BUTYL PENTAPEPTIDE
1'-DEMETHYL-1'-[3-PHENYL-N-(PHTHALIMIDOACETYL)ALANYL]NICOTINE
Geodiamolide I
Methyl 1-(8-(4-[(ethoxycarbonyl)amino]butyl)-2-(4-[(ethoxycarbonyl)oxy]benzyl)-5,11-diisopropyl-4,7,10,13-tetraoxo-14-oxa-3,6,9,12-tetraazahexadec-1-anoyl)-2-pyrrolidinecarboxylate
XVHXYERWGQPAEM-CFZAOCBJSA-N
Crytophycin A
CRYPTOPHYCIN-A
| Title | Journal or Book | Year |
|---|---|---|
| X-ray Structure of Citrate Bound to Src SH2 Leads to a High-Affinity, Bone-Targeted Src SH2 Inhibitor | Journal of Medicinal Chemistry | 2001 |